Life science venture investing and incubation firm PureTech Health looks to raise $160 million in an initial public offering on the London Stock Exchange.
(Reuters) — Boston-based PureTech Health plans to raise $160 million in a London listing, filling its coffers to fund product development and delivering a vote of confidence on the British life sciences sector.
The move by the U.S. health technology firm follows a similar decision by California-based drug discovery group Verseon to raise $100 million in London earlier this month.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AvhOs3
Cap comentari:
Publica un comentari a l'entrada